Latest News Site

News

This pill may help curb 2.7 lakh HIV cases in India

This pill may help curb 2.7 lakh HIV cases in India
May 11
18:01 2019
  • Their findings suggest that PrEP would increase survival substantially by reducing infection risk, while more frequent HIV testing would provide little additional benefit.

New Delhi, May 11 : Paired with a biannual testing programme, a combination drug used to prevent HIV infection has the potential to improve average per-person survival by nearly one year and block more than 270,000 HIV transmissions in India over a period of 15 years, says a study.

prophylaxis (PrEP)

These tablets are being produced and marketed by cipla Ltd. a big pharmaceutical Company in india. Approximate price Rs 4438 for 100 grm pack.

The once-a-day pill, called pre-exposure prophylaxis (PrEP), can reduce the risk of HIV acquisition by over 85 per cent when taken consistently.

The new study, published in the journal Clinical Infectious Diseases, suggests that making PrEP available to men who have sex with men (MSM) and people who inject drugs (PWID) in India may be a cost-effective way of curbing the epidemic in the country.

the journal Clinical Infectious Diseases

“We know PrEP helps stop the spread of infection; the question is whether it is a good use of limited resources? Our study shows that PrEP is a cost-effective strategy for both MSM and PWID in India. For these groups, especially in areas with high HIV incidence, PrEP is worth rolling out,” says lead and corresponding author Pooyan Kazemian of the Massachusetts General Hospital (MGH) in the US.

Regional Director, Dr Poonam Khetrapal Singh with His Excellency Mr J P Nadda

Using a widely-published mathematical model to project clinical and economic outcomes of HIV disease, the authors compared various prevention and testing programmes – including annual or biannual HIV testing alone, as well as PrEP paired with HIV testing – that could help reduce HIV infection and therefore improve survival for these high-risk groups.

Their findings suggest that PrEP would increase survival substantially by reducing infection risk, while more frequent HIV testing would provide little additional benefit.

Who Jpeg

“While the World Health Organization recommends quarterly HIV testing for those on PrEP, our analysis identifies PrEP with semi-annual testing as the cost-effective HIV prevention strategy for MSM and PWID in India,” said co-author Nagalingeswaran Kumarasamy of the Voluntary Health Services in Chennai.

However, the authors noted that a nationwide PrEP rollout would be quite costly.

Amitabh

If nearly 60 per cent of MSM and PWID across India participated in the programme, it would increase HIV care expenditures by over $900 million over a five-year period, the study said.

“Our findings suggest that geographic areas of highest HIV incidence should be targeted first to reduce the budget required,” said co-author Nomita Chandhiok of the Indian Council of Medical Research in New Delhi.

IANS

 

Ranbir Kapoor practices ‘Shiva sessions’ in Berlin

G.E.L Shop Association
kallu
Novelty Fashion Mall
Fly Kitchen
Harsha Plastics
Status
Tanishq
Akash
Swastik Tiles
Reshika Boutique
Paul Opticals
Metro Glass
Krsna Restaurant
Motilal Oswal
Chotanagpur Handloom
Kamalia Sales
Home Essentials
Raymond

About Author

admin_news

admin_news

Related Articles

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment

Sponsored Ad

SPONSORED ADS SPONSORED ADS SPONSORED ADS

LATEST ARTICLES

    Rosatom completes equipment supply for 3rd Kudankulam power plant

Rosatom completes equipment supply for 3rd Kudankulam power plant

0 comment Read Full Article

Subscribe to Our Newsletter